Zdrowie i gospodarka · 20/03/2012
FDA Amends Good Manufacturing Practice Regulations for Drug Labeling
The FDA is revising labeling controls for human and veterinary drug products to reduce labeling errors and eliminate regulatory burdens, allowing for more flexible error prevention and labeling techniques.
Source: Federal Register — Food and Drug AdministrationOpen original release →